Patents Assigned to Naidu LP
-
Patent number: 9283253Abstract: Formulations are provided for detoxification support. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber such as glucomannan and includes Metallo-Lactoferrin protein in an alkaline buffer system. The elemental complex includes one or more trace element as a suitable salt. The coenzyme-vitamin B complex includes one or more coenzyme, coenzyme precursor and/or B-vitamin. The compositions may optionally include additional components such as Lactic Acid bacteria, L-theanine, cranberry root extract, tumeric root extract, inulin and blond psyllium. The compositions can be administered orally in a variety of forms.Type: GrantFiled: July 1, 2013Date of Patent: March 15, 2016Assignee: NAIDU LPInventors: A. Satyanarayan Naidu, A.G. Tezus Naidu, A.G. Sreus Naidu
-
Patent number: 9181536Abstract: Stabilized angiogenin compositions and methods of preparing a stabilized angiogenin compositions by covalent immobilization on a naturally occurring substrate, such as a polysaccharide substrate, are disclosed. In particular, the polysaccharide substrate includes galactose-rich polysaccharide.Type: GrantFiled: August 27, 2014Date of Patent: November 10, 2015Assignee: NAIDU LPInventor: A. Satyanarayan Naidu
-
Patent number: 9180148Abstract: Formulations are provided for the management of weight. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber such as glucomannan and includes Metallo-Lactoferrin protein in an alkaline buffer system. The elemental complex includes one or more trace element as a suitable salt. The coenzyme-vitamin B complex includes one or more coenzyme, coenzyme precursor and/or B-vitamin. The compositions may optionally include additional components such as dihydroxy acetone (DHA), inositol, 5-hydroxy-L-tryptophan (5-HTP), choline, milk protein hydrolysate, and pyruvate. The compositions can be administered orally in a variety of forms and may substitute for one or more meals per day to manage weight.Type: GrantFiled: July 1, 2013Date of Patent: November 10, 2015Assignee: NAIDU LPInventors: A. Satyanarayan Naidu, A. G. Tezus Naidu, A. G. Sreus Naidu
-
Patent number: 8968726Abstract: Compositions are described which contain lactoferrin and angiogenin. The described compositions are useful in treatment of a variety of conditions, particularly in promoting bone health and relief of menopausal symptoms.Type: GrantFiled: August 5, 2011Date of Patent: March 3, 2015Assignee: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Tezus Naidu, A. G. Sreus Naidu
-
Patent number: 8940687Abstract: Antimicrobial compositions based upon stabilized angiogenin compositions also contain osteopontin and antimicrobial proteins such as lactoperoxidase (LPO), myeloperoxidase (MPO), salivary peroxidase (SPO) and lysozyme.Type: GrantFiled: April 11, 2013Date of Patent: January 27, 2015Assignee: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Tezus Naidu, A. G. Sreus Naidu
-
Patent number: 8840883Abstract: Metallo-proteins including but not limited to lactoferrin (LF), transferrin (TF) and ovotransferrin (OTF) (all members of transferrin family), ceruloplasmin (CP) and metallo-thionein (MT) were found to stabilize and enhance the bio-functional activity of tocotrienol (T3), T3 mixtures or derivates. The synergism between MP and T3 also promote the intestinal transfer and the ultimate bio-availability of T3 and T3-derivatives for physiological functions. Such functional synergism includes hypocholesterolemic, anti-thrombotic, antioxidant, anti-athermogenic, anti-inflammatory and immuno-regulatory activities of T3 agents. Addition of a non-protein-type metal chelator provided further improvement in the action of the bio-functional activity of T3. These T3 compositions are useful as pharmaceuticals, in cosmetics, in foods and as nutritional supplements.Type: GrantFiled: November 9, 2012Date of Patent: September 23, 2014Assignee: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Sreus Naidu, A. G. Tezus Naidu
-
Patent number: 8828698Abstract: Stabilized angiogenin compositions and methods of preparing a stabilized angiogenin compositions by covalent immobilization on a naturally occurring substrate, such as a polysaccharide substrate, are disclosed. In particular, the polysaccharide substrate includes galactose-rich polysaccharide.Type: GrantFiled: April 12, 2007Date of Patent: September 9, 2014Assignee: Naidu LPInventor: A. Satyanarayan Naidu
-
Patent number: 8476223Abstract: Formulations are provided for the improvement of sleep patterns. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber such as glucomannan and includes Metallo-Lactoferrin protein in an alkaline buffer system. The elemental complex includes one or more trace element as a suitable salt. The coenzyme-vitamin B complex includes one or more coenzyme, coenzyme precursor and/or B-vitamin. The compositions may optionally include additional components such as 5-hydroxy-L-tryptophan (5-HTP), choline, melatonin, milk protein hydrolysate, L-arginine, and L-carnitine. The compositions can be administered orally in a variety of forms.Type: GrantFiled: April 28, 2011Date of Patent: July 2, 2013Assignee: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Tezus Naidu, A. G. Sreus Naidu
-
Patent number: 8440183Abstract: Stabilized angiogenin compositions and methods of preparing stabilized angiogenin compositions by immobilization on a lipid-based substrate, such as a phospholipid or Coenzyme-Q10, are disclosed.Type: GrantFiled: July 18, 2011Date of Patent: May 14, 2013Assignee: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Tezus Naidu, A. G. Sreus Naidu
-
Publication number: 20130071372Abstract: Metallo-proteins including but not limited to lactoferrin (LF), transferrin (TF) and ovotransferrin (OTF) (all members of transferrin family), ceruloplasmin (CP) and metallo-thionein (MT) were found to stabilize and enhance the bio-functional activity of tocotrienol (T3), T3 mixtures or derivates. The synergism between MP and T3 also promote the intestinal transfer and the ultimate bio-availability of T3 and T3-derivatives for physiological functions. Such functional synergism includes hypocholesterolemic, anti-thrombotic, antioxidant, anti-athermogenic, anti-inflammatory and immuno-regulatory activities of T3 agents. Addition of a non-protein-type metal chelator provided further improvement in the action of the bio-functional activity of T3. These T3 compositions are useful as pharmaceuticals, in cosmetics, in foods and as nutritional supplements.Type: ApplicationFiled: November 9, 2012Publication date: March 21, 2013Applicant: Naidu LPInventor: Naidu LP
-
Publication number: 20130064803Abstract: Methods to prepare a bio-replenishment (BioRep) with specific combinations of S-adenosylmethionine (SAMe), lactoferrin (LF) and ribonuclease (RNAse) to restore cognitive health are disclosed. These methods have implications in the clinical management of cognitive afflictions such as anxiety, dementia and depression.Type: ApplicationFiled: September 12, 2012Publication date: March 14, 2013Applicant: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Sreus Naidu
-
Publication number: 20130064804Abstract: Methods to prepare a bio-replenishment (BioRep) with specific combinations of S-adenosylmethionine (SAMe), lactoferrin (LF) and ribonuclease (RNAse) to restore regular sleep pattern are described. Additionally, compositions of functional delivery systems that recreate both alternate phases of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep cycles are disclosed. These methods and compositions have implications in the clinical management of various sleep disorders including insomnia, circadian rhythm disorders and obstructive sleep apnea.Type: ApplicationFiled: September 12, 2012Publication date: March 14, 2013Applicant: Naidu LPInventors: A. Satyanarayan Naidu, A.G. Sreus Naidu
-
Patent number: 8309080Abstract: Metallo-proteins including but not limited to lactoferrin (LF), transferrin (TF) and ovotransferrin (OTF) (all members of transferrin family), ceruloplasmin (CP) and metallo-thionein (MT) were found to stabilize and enhance the bio-functional activity of tocotrienol (T3), T3 mixtures or derivates. The synergism between MP and T3 also promote the intestinal transfer and the ultimate bio-availability of T3 and T3-derivatives for physiological functions. Such functional synergism includes hypocholesterolemic, anti-thrombotic, antioxidant, anti-athermogenic, anti-inflammatory and immuno-regulatory activities of T3 agents. These T3 compositions are useful as pharmaceuticals, in cosmetics, in foods and as nutritional supplements.Type: GrantFiled: December 3, 2008Date of Patent: November 13, 2012Assignee: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Sreus Naidu, A. G. Tezus Naidu
-
Publication number: 20110286989Abstract: Stabilized angiogenin compositions and methods of preparing stabilized angiogenin compositions by immobilization on a lipid-based substrate, such as a phospholipid or Coenzyme-Q10, are disclosed.Type: ApplicationFiled: July 18, 2011Publication date: November 24, 2011Applicant: Naidu LPInventor: A. Satyanarayan Naidu
-
Publication number: 20110286986Abstract: Compositions are described which contain lactoferrin and angiogenin. The described compositions are useful in treatment of a variety of conditions, particularly in promoting bone health and relief of menopausal symptoms.Type: ApplicationFiled: August 5, 2011Publication date: November 24, 2011Applicant: Naidu LPInventors: A. Satyanarayan Naidu, A.G. Tezus Naidu, A.G. Sreus Naidu
-
Patent number: 8021659Abstract: Methods of enhancing the bio-availability of coenzyme Q10, and methods of supporting the cardiovascular system to accommodate the increase in cellular energy synthesis as a result of the bio-availability of coenzyme Q10 are described. Compositions which include coenzyme Q10, lactoferrin and/or angiogenin are described for use in the related methods, for multi-functional health applications.Type: GrantFiled: July 7, 2006Date of Patent: September 20, 2011Assignee: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Tezus Naidu, A. G. Sreus Naidu
-
Patent number: 8003603Abstract: Stabilized angiogenin compositions and methods of preparing a stabilized angiogenin compositions by non-covalent immobilization on a naturally occurring substrate, such as a protein, lipid, nucleic acid or nucleotide substrate, are disclosed.Type: GrantFiled: September 4, 2009Date of Patent: August 23, 2011Assignee: Naidu LPInventor: A. Satyanarayan Naidu
-
Publication number: 20110200575Abstract: Formulations are provided for the improvement of sleep patterns. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber such as glucomannan and includes Metallo-Lactoferrin protein in an alkaline buffer system. The elemental complex includes one or more trace element as a suitable salt. The coenzyme-vitamin B complex includes one or more coenzyme, coenzyme precursor and/or B-vitamin. The compositions may optionally include additional components such as 5-hydroxy-L-tryptophan (5-HTP), choline, melatonin, milk protein hydrolysate, L-arginine, and L-carnitine. The compositions can be administered orally in a variety of forms.Type: ApplicationFiled: April 28, 2011Publication date: August 18, 2011Applicant: Naidu LPInventors: A. Satyanarayan Naidu, A.G. Tezus Naidu, A.G. Sreus Naidu
-
Patent number: 7956031Abstract: Formulations are provided for the trigger and release of bioenergy. The formulations generally include a trigger complex, an elemental complex and a coenzyme-vitamin B complex. The trigger complex is high in fiber and includes at least one metal-binding protein in an alkaline buffer system. The elemental complex includes one or more trace element as a suitable salt. The coenzyme-vitamin B complex includes one or more coenzyme, coenzyme precursor and/or B-vitamin. The compositions can be administered orally in a variety of forms.Type: GrantFiled: May 26, 2006Date of Patent: June 7, 2011Assignee: Naidu LPInventors: A. Satyanarayan Naidu, A. G. Tezus Naidu, A. G. Sreus Naidu
-
Publication number: 20100021449Abstract: Stabilized angiogenin compositions and methods of preparing a stabilized angiogenin compositions by non-covalent immobilization on a naturally occurring substrate, such as a protein, lipid, nucleic acid or nucleotide substrate, are disclosed.Type: ApplicationFiled: September 4, 2009Publication date: January 28, 2010Applicant: Naidu LPInventor: A. Satyanarayan Naidu